A new report from a bipartisan panel created by the US Senate stated that China has been enhancing its efforts "to control the pharmaceutical supply chain from medicine manufacturing to novel ...
AbbVie is twirling onto the dance floor with Disco Pharmaceuticals, offering up to $2.5 billion to work with the German ...
December 2025 marked an exceptionally active period for life sciences regulation in the European Union (EU). Within the space of a few days, EU institutions have reached political agreement on the ...
The Marine Biotechnology Market is projected to grow at a CAGR of 6.93% from 2027 to 2032, with North America maintaining its position as the leading regional market.Hyderabad, India, Nov. (GLOBE ...
TNF new strategic partner LightSolver named a 2025 World Economic Forum Technology Pioneer and recognized in Gartner’s 2025 Hype Cycle for Data Center Infrastructure Technologies LAS VEGAS--(BUSINESS ...
Both ETFs offer investors a way to profit from advances in medicine, but a closer look reveals a clear winner.
The biotech industry is primed for increased M&A activity due to low valuations and big pharma's need to offset patent losses. Mirum Pharmaceuticals, with three approved drugs and a strong pipeline, ...
Ionis Pharmaceuticals lost more than $1 billion in market value on Monday after the company slashed sales projections for a ...
The oncology biotech could go public in a SPAC reverse takeover, though an IPO is not guaranteed.
Blue Wave election results could reshape healthcare policy. Click to discover stocks that need to be watched in the Big Pharma and biotech sectors.
The explosive move has catapulted the profitable biotech onto the Investor's Business Daily Breakout Stocks Index and the IBD ...